Epclusa

Epclusa is a combination medication containing Sofosbuvir and Velpatasvir, used for treating chronic hepatitis C. This oral medication is designed to target the virus and support liver health.

Epclusa is primarily used for the treatment of chronic hepatitis C virus (HCV) infection. It works by targeting the virus to help manage the condition. The medication is often prescribed as part of a comprehensive treatment plan to support liver health and overall well-being.

Common effects of Epclusa may include fatigue, headache, and nausea. Some individuals might experience dizziness or insomnia. These effects can vary from person to person and are not experienced by everyone who takes the medication.

Epclusa should be used under the guidance of a healthcare professional. It is important to inform your healthcare provider about any other medications you are taking to avoid potential interactions. Regular monitoring may be required during treatment.

Epclusa can interact with other medications, including certain antacids and some HIV medications. It is important to discuss all current medications with a healthcare provider to ensure safe and effective use. Alcohol consumption should be avoided during treatment.